IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Psyence Biomedical LTD (PBM)

CUSIP: 74449F407 | NYSE | 9 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/APsyence Labs Ltd.2,643,65949.8%New 5%+ stakeOct 1, 2026No 13F filer matched
13GAdvisorShares Trust258,5386.8%New 5%+ stakeSep 30, 2026

Institutional Holders — Q3 2026

AdvisorShares Investments LLC258,538
0.2% of portfolio›$1.4M
Parallel Advisors, LLC151,250
0.0% of portfolio›$574.8K
UBS Group AG330
0.0% of portfolio›$1.8K
StyleTurnoverLocationFiled
AdvisorShares Investments LLC
258,538$1.4M0.2%Deep ValueVery HighBethesda, MD2026-11-09
Parallel Advisors, LLC
151,250$574.8K0.0%GrowthLowSan Francisco, CA2026-11-03
UBS Group AG
330$1.8K0.0%CoreMediumZurich, Switzerland2026-11-10
No 13F filer matched
13D/APsyence Labs Ltd.2,643,659
49.8% of class · Oct 1, 2026New 5%+ stake
No 13F filer matched
13GAdvisorShares Trust258,538
6.8% of class · Sep 30, 2026New 5%+ stake
No 13F filer matched